That is exactly what I was saying. People are getting Remdesivir because it's been approved and if they DON'T get it and die, the families might claim it's malpractice. But it isn't -- the EU doesn't think it has enough efficacy to recommend it for treatment.
(3)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links